Table 3.

Multivariate competing risks analyses.

Variables	Sub-hazard ratio	95% CI	p-value
Lung cancer–specific survival, segmentectomy vs. lobectomy
Segmentectomy	1.005	0.620–1.628	0.984
Gender	1.394	0.960–2.025	0.081
Year of surgery	0.859	0.744–0.991	0.037
Tumor grade	2.145	1.684–2.733	<0.001
T stage	1.326	1.053–1.670	0.016
Non-cancer–specific survival, segmentectomy vs. lobectomy
Segmentectomy	1.093	0.667–1.790	0.724
Age	1.052	1.004–1.103	0.034
T stage	1.283	1.048–1.569	0.016
Lung cancer–specific survival, wedge resection vs. lobectomy
Wedge resection	1.226	0.870–1.727	0.245
Age	1.030	0.995–1.066	0.090
Gender	1.396	1.065–1.829	0.016
Year of surgery	0.908	0.820–1.005	0.062
Tumor grade	1.689	1.407–2.028	<0.001
T stage	1.336	1.152–1.551	<0.001
Lymph node harvesting	0.680	0.554–0.834	<0.001
Non-cancer–specific survival, wedge resection vs. lobectomy
Wedge resection	1.249	0.934–1.670	0.134
Gender	1.454	1.084–1.951	0.012
Year of surgery	0.858	0.762–0.967	0.012
T stage	1.170	1.006–1.362	0.042